Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017846 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2
A Phase 2 study of Molluscum Contagiosum, sponsored by Steven R Cohen.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03017846 is a Phase 2 study of Molluscum Contagiosum that has completed, run by Steven R Cohen. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03017846, a Phase 2 study of Molluscum Contagiosum, has completed, sponsored by Steven R Cohen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Cantharidin is cited in the dermatology and pediatric literature as a valuable treatment option. Treatment is often available in private practice offices, where a prescribing physician may offer a non-FDA approved treatment on an individualized basis. The situation is different in many hospital and academic settings, such as our own for example, where the formulary is defined through a FDA-approved indication. The absence of an indication precludes its addition to many hospital formularies, thus limiting the options available to a prescribing physician and denying patient access to a treatment offered in the private practice setting. An indication and formulary status require controlled clinical trials on the safety and efficacy of cantharidin in MC. The objective of this trial is to see if this commercially-viable cantharidin formulation has a comparable safety and efficacy profile as formulations previously studied under conditions which most closely match the what has been historically done in the clinic.
Conditions Studied
Interventions
- DRUG Cantharidin
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-09-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03017846
The ClinicalTrials.gov registry entry for NCT03017846 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steven R Cohen, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Molluscum Contagiosum appearing as the primary indexed condition, and to 1 intervention - of which Cantharidin is the first listed.
NCT03017846 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03017846 about?
NCT03017846 is a clinical study titled "Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2". Cantharidin is cited in the dermatology and pediatric literature as a valuable treatment option. Treatment is often available in private practice offices, where a prescribing physician may offer a non-FDA approved treatment on an individualized basis. The situation is different in many hospital and ...
What is the current status of trial NCT03017846?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2016-09. Estimated completion is 2017-09-06.
What conditions does trial NCT03017846 study?
This clinical trial studies the following conditions: Molluscum Contagiosum.
What interventions are being tested in trial NCT03017846?
The interventions under investigation include: Cantharidin (DRUG).
Who is sponsoring clinical trial NCT03017846?
This trial is sponsored by Steven R Cohen, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03017846 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Molluscum Contagiosum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.